Inflexion is delighted to have been named Mid-Market Firm of the Year in EMEA in the Private Equity International Awards 2025.
The award recognises a period of strong performance for Inflexion and its portfolio, during the judging period (1st November 2024 – 31st October 2025) which saw nine exits generating €3.2 billion of proceeds for investors with an average gross return of 3.7x and average gross IRR of 33 percent. This included the sale of premium skincare brand Medik8 to L’Oréal, one of 2025’s largest beauty transactions.
Over the period Inflexion also announced 10 new investments with combined equity value of €3.2 billion and supported 84 portfolio acquisitions across 14 countries, taking total backed acquisitions to more than 600.
The firm raised its first Continuation Fund at £2.3 billion, the largest multi asset continuation fund raised in Europe to date. Inflexion also continued its international expansion with the launch of a North American office in 2025 focused on supporting transformational M&A for its portfolio.
Inflexion further invested in its people and platform, including the promotion of Flor Kassai to Managing Partner, 27 promotions and 36 new appointments across the firm. The Inflexion Foundation committed £3.7 million to 32 charities during the period.
This award underscores the breadth and resilience of our European platform. It is a testament to the confidence our investors place in us and the drive of the management teams we partner with across the region. We are proud of our collective achievements in Europe and remain committed to helping businesses scale sustainably and generate exceptional outcomes.
Contact us
Please contact us if you have any media enquiries
